A PSMA PET/MRI scan obtained for the assessment of men with BCR after treatment of prostate cancer should include small FOV T2 images of the abdomen and pelvis and DCE MRI of the pelvis to improve co-localization of suspicious findings identified on PSMA PET. This evidence concerns the gene BCR and Familial prostate cancer.